Clinical Trial Update: Treatment of Chronic Critical Limb Ischemia With G-CSF-mobilized Autologous Peripheral Blood Mononuclear Cells [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating G-CSF-mobilized autologous peripheral blood mononuclear cells for treatment of chronic critical limb ischemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Critical Limb Ischemia
• Gangrene
• Ischemic Ulcer

Drugs mentioned

• G-CSF-mobilized autologous peripheral blood mononuclear cells

Snippet

Sponsor: Mahidol University | Conditions: Critical Limb Ischemia, Atherosclerosis | Phase 3 | Status: COMPLETED